Philip A. Johnston

Amministratore Delegato presso Qualcare Management Pty Ltd.

Health Technology

Profilo

Philip A.
Johnston is currently the Managing Director at Qualcare Management Pty Ltd.
He previously held positions as Non-Executive Chairman at Kazia Therapeutics Ltd.
from 2001 to 2010, Director at Glycotex, Inc., and Non-Executive Director at MEI Pharma, Inc. from 2001 to 2011.
Prior to that, he was the Executive Director at Wellcome Australia Ltd.
from 1988 to 1997.

Posizioni attive di Philip A. Johnston

Società	Posizione	Inizio
Qualcare Management Pty Ltd.	Amministratore Delegato	15/04/2011

Tutte le posizioni attive di Philip A. Johnston

Precedenti posizioni note di Philip A. Johnston

Società	Posizione	Fine
MEI PHARMA, INC.	Direttore/Membro del Consiglio	13/04/2011
KAZIA THERAPEUTICS LIMITED	Presidente	19/10/2010
Wellcome Australia Ltd.	Direttore/Membro del Consiglio	01/09/1997
Glycotex, Inc. Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di Philip A. Johnston

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Philip A. Johnston

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
KAZIA THERAPEUTICS LIMITED	Health Technology
MEI PHARMA, INC.	Health Technology

Aziende private	3
Glycotex, Inc. Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD	Health Technology
Wellcome Australia Ltd.
Qualcare Management Pty Ltd.

Vedi le connessioni aziendali

Borsa valori
Insiders
Philip A. Johnston